From: Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience
 |  | DDD n(%) | C3GN n(%) |
---|---|---|---|
Age | Mean ± SD(years) | 25.08(±13.09) | 33(±16.91) |
Range(years) | 12-51 | 14-64 | |
Sex | Male | 8 | 11 |
Female | 5 | 3 | |
Nephrotic | 7/13(53.9%) | 4/14 (28.6%) | |
Nephrotic/nephritic | 02/13 (15.4%) | 08 (57.1%) | |
ESRD | 04/13(30.8%) | 02(14.3%) | |
Hypertension | 2(16.7) | 9(64.23) | |
Oliguria | 1(8.3) | 3(66.7) | |
Dyslipidemia | 7 | 0 | |
ANA | 0 | 0 | |
ANCA | 0 | 0 | |
HBsAg | 1(7.69) | 0 | |
HCV | 0 | 0 | |
HIV | 0 | 0 | |
Low C3 levels | 6(85.71) | 0 | |
Low C4 levels | 1(14.29) | 0 |